Delivery Order SPE2DB20D2001-SPE2DB23FM69W
- Not listed
- This federal contract award, valued at $11,034.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,557,995,743 units of the medication DETROL LA 4 MG CAPSULE 500S. The contract is a delivery order with a firm fixed price and has an ultimate completion date of August 5, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $12,878.43, is for the delivery of Detrol LA 2 mg capsules to support federal healthcare programs. The contract is a firm fixed-price delivery order with an ultimate completion date of November 8, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $27,579.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of DETROL LA 4 MG CAPSULE 90S, a pharmaceutical product. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 28, 2023. The contract was awarded on a full and open competition basis, with no set-aside designation. Amerisourcebergen Drug Corp,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $25,716.46 for the supply of DETROL LA 2 MG CAPSULE 500S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency within the Department of Defense. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, valued at $8,313.25, is for the delivery of Detrol LA 2 mg capsules and has an ultimate completion date of January 30, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $18,050.09 firm-fixed-price delivery order is for the supply of DETROL LA 4 MG CAPSULE 90S, a pharmaceutical product. The award has an ultimate completion date of May 4, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of DETROL LA 4 MG CAPSULE 500S. The firm-fixed-price delivery order, valued at $13,566.41, has a completion date of September 22, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,606.16 firm fixed price delivery order is for the supply of DETROL LA 4 MG CAPSULE 90S, a medication for overactive bladder. The contract has an ultimate completion date of April 21, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,058.00, is for the delivery of Detrol LA 4 mg capsules. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,073.12 firm-fixed-price delivery order is for the supply of DETROL LA 2 MG CAPSULE 90S, a prescription medication. The contract has an ultimate completion date of November 1, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB23FM69WDelivery Order
This federal contract award, valued at $14,452.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of DETROL LA 4 MG CAPSULE 500S, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is August 24, 2023. The contract was awarded on August 23, 2023, and there was no set-aside designation used. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.5k | 8/23/23 |